Literature DB >> 32140765

Abnormal things happening during sleep: parasomnias.

S Stieglitz1,2, H J Heppner3, N Netzer4.   

Abstract

Parasomnias are characterized by abnormal experiences, dreams, movements and behavior during sleep. They may occur in the middle of the sleep during REM (rapid eye movement) or NREM (non-rapid eye movement), during falling asleep or waking up. Characteristically for REM behavior disorder is an increased muscle tone although usually REM is defined by an absence of muscle tone. For these forms aggressive dreams may lead to violating bed partners or self-injury of the sleeping person. Even killing bed partners has been described. Many of the patients develop a kind of Parkinson's disease (synucleinopathies). The rate of phenoconversion is more than 30% in 5 years and nearly 100% after 15 years. There are several recommendations regarding a safe sleeping environment. Medicinal treatment consists of either melatonin or clonazepam.

Entities:  

Keywords:  Parkinson’s disease; REM sleep without atonia; Rapid eye movement; Sleep behavior disorder; Sleep paralysis

Mesh:

Year:  2020        PMID: 32140765     DOI: 10.1007/s00391-020-01714-5

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  15 in total

Review 1.  International classification of sleep disorders-third edition: highlights and modifications.

Authors:  Michael J Sateia
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

Review 2.  Extending healthy life span--from yeast to humans.

Authors:  Luigi Fontana; Linda Partridge; Valter D Longo
Journal:  Science       Date:  2010-04-16       Impact factor: 47.728

Review 3.  Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.

Authors:  Claudio L A Bassetti; Antoine Adamantidis; Denis Burdakov; Fang Han; Steffen Gay; Ulf Kallweit; Ramin Khatami; Frits Koning; Brigitte R Kornum; Gert Jan Lammers; Roland S Liblau; Pierre H Luppi; Geert Mayer; Thomas Pollmächer; Takeshi Sakurai; Federica Sallusto; Thomas E Scammell; Mehdi Tafti; Yves Dauvilliers
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

4.  Not Only Sleepwalking But NREM Parasomnia Irrespective of the Type Is Associated with HLA DQB1*05:01.

Authors:  Anna Heidbreder; Birgit Frauscher; Thomas Mitterling; Matthias Boentert; Anja Schirmacher; Paul Hörtnagl; Harald Schennach; Christina Massoth; Svenja Happe; Geert Mayer; Peter Young; Birgit Högl
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

5.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia.

Authors:  C H Schenck; S R Bundlie; M G Ettinger; M W Mahowald
Journal:  Sleep       Date:  1986-06       Impact factor: 5.849

6.  Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.

Authors:  Alex Iranzo; Eduard Tolosa; Ellen Gelpi; José Luis Molinuevo; Francesc Valldeoriola; Mónica Serradell; Raquel Sanchez-Valle; Isabel Vilaseca; Francisco Lomeña; Dolores Vilas; Albert Lladó; Carles Gaig; Joan Santamaria
Journal:  Lancet Neurol       Date:  2013-04-03       Impact factor: 44.182

Review 7.  REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions.

Authors:  Erik K St Louis; Bradley F Boeve
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

8.  The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants.

Authors:  Kenneth Lee; Kelly Baron; Rodolfo Soca; Hrayr Attarian
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

9.  REM sleep behavior disorder in Parkinson's disease: A case from India confirmed with polysomnographic data.

Authors:  Ravi Gupta; Deepak Goel; Jim Walker; Robert J Farney
Journal:  J Neurosci Rural Pract       Date:  2013-08

10.  Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.

Authors:  Alex Iranzo; Ana Fernández-Arcos; Eduard Tolosa; Mónica Serradell; José Luis Molinuevo; Francesc Valldeoriola; Ellen Gelpi; Isabel Vilaseca; Raquel Sánchez-Valle; Albert Lladó; Carles Gaig; Joan Santamaría
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.